Browsing Tag
Island Pharmaceuticals
5 posts
Island Pharmaceuticals (ASX: ILA) awaits FDA clearance for Galidesivir as Animal Rule review enters final phase
Island Pharmaceuticals confirms no FDA setbacks on Galidesivir. Find out what this means for its Marburg virus study and broader regulatory strategy.
Island Pharmaceuticals stock climbs as FDA clears path for Galidesivir fast-track review
Island Pharmaceuticals (ASX: ILA) stock rises as FDA fast-tracks Galidesivir under the Animal Rule, with survival data, PRV potential, and stockpile contracts in focus.
Island Pharmaceuticals announces completion of ISLA-101 dosing study
In a significant development in the fight against dengue fever, Island Pharmaceuticals Ltd (ASX: ILA), a leading Australian…
Island Pharmaceuticals advances in dengue treatment: Completes second phase of ISLA-101 study
Australia-based Island Pharmaceuticals Ltd (ASX: ILA) has achieved a significant milestone in its quest to combat mosquito-borne diseases,…
Island Pharmaceuticals commences key dengue fever drug trial in Australia
Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA), has reached a milestone with the commencement of…